Sanginita Chemicals: Open Offer to acquire 26% stake at ₹13.55 per share
Sanginita Chemicals announces an Open Offer to acquire 1,56,89,957 equity shares (26%) at ₹13.55 per share, totaling ₹21.26 crore. This is part of a larger transaction involving share swap and purchase agreements, and a preferential issue of 3,44,44,436 shares. Agastya Green Energy Limited will become a wholly-owned subsidiary.
The open offer to acquire a substantial 26% stake and the change in control of a subsidiary represent a significant corporate action that will materially affect the company's shareholding structure and future operations.
The open offer and the underlying transactions indicate a significant strategic move and potential investment in the company, which is generally viewed positively by the market.
Sanginita Chemicals Limited has announced an Open Offer to acquire 1,56,89,957 equity shares, representing 26% of the emerging fully diluted voting equity share capital, from its public shareholders. The offer price is ₹13.55 per equity share, with the total consideration estimated at ₹21,25,98,917.35. This open offer is triggered by a Share Swap and Share Purchase Agreement (SSSPA) executed on March 20, 2026, involving Sanginita Industries LLP, Dineshsinh Bhimsingh Chavada, Vijaysinh Dineshsinh Chavada, Hansaben Dineshsinh Chavada, Anita Ravindrasinh Aswar (collectively, the Sellers), B N G Investment LLC, and Mr. Anubhav Agarwal (collectively, the Acquirers). The underlying transactions include the acquisition of 65,78,994 equity shares by the Acquirers from the Sellers and a preferential issue of 3,44,44,436 equity shares to Acquirer 1. The preferential issue comprises the issuance of 1,52,87,356 equity shares to B N G Investment LLC in consideration for acquiring 95,00,000 equity shares of Agastya Green Energy Limited (AGEL), and the issuance of 1,91,57,080 equity shares to B N G Investment LLC for cash consideration at ₹13.05 per equity share. Consequently, AGEL will become a wholly-owned subsidiary of Sanginita Chemicals Limited. A Detailed Public Statement (DPS) will be published on or before March 30, 2026. The Acquirers intend to retain the listing status of Sanginita Chemicals Limited.
What to do with a filing like this
Sanginita Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under substantial acquisition of shares and takeovers. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Sanginita Chemicals Limited. Read the original for the full detail.